Bridging clinical gaps
Medimaps is an innovative software company with proven clinical expertise. Recognized for our authority in medical densitometry, we focus our research and development (R&D) capabilities to drive a leading product pipeline in bone microarchitecture assessment.
Our ambition is to bring to the market a suite of transformative non-invasive software solutions that deliver unparalleled insights into bone health, elevating the standard of care and aiming to improve quality of life for healthy aging.
Addressing current challenges in osteoporosis
According to the International Osteoporosis Foundation, an osteoporotic fracture occurs every 3 seconds, making osteoporosis a public health challenge. Early detection can enable patients to manage the disease and avoid fracturing, however only a portion of patients at risk are being screened on time.
The burden of osteoporosis
500 Million
men and women worldwide have osteoporosis1
40-50%
of osteoporotic fractures occur in patients that do not meet criteria for osteoporosis by BMD T-score2
~70%
of patients who fracture have never been referred to dual-energy X-ray absorptiometry (DXA) and are not receiving treatment3
Leveraging AI to elevate the standard of care
Because osteoporosis and musculoskeletal conditions remain largely underdiagnosed and undertreated, Medimaps focuses its R&D on novel non-invasive software as a medical device that have the potential to enhance the screening, diagnosis and monitoring of bone diseases and impact of treatments.
Powered by artificial intelligence methodologies, our products under development seamlessly integrate into the clinical workflow to maximize clinicians’ adoption.
Equipped with interoperability features, our sophisticated software solutions are designed to deliver impactful clinical data and conclusions, saving manual processing time for the benefit of clinicians and patients, for enhanced treatment decisions.
Present at every stage of the patient journey
In osteoporosis, and other musculoskeletal conditions, patients will require several radiologic examinations in order to diagnose and monitor the evolution of their bone health, providing as many opportunities to check their bone status for an exhaustive health evaluation.
Supported by artificial intelligence methodologies, our software under development assess patients bone microarchitecture through differentiated imaging modalities to evaluate their bone health and inform treatment decisions.
Watch this video to learn more
Learn more about our suite of software solutions
Our portfolio supports healthcare professionals throughout the entire patient journey to capture potential individuals at risk of fracturing, from opportunistic screening, enhancing fracture risk assessment to orthopedic surgical decision-making. Click below to learn more about our commercial solutions and products under development.
1. International Osteoporosis Foundation, Facts and Figures
2. Siris et al. Arch Intern Med 2004
3. Kanis et al., Osteoporos Int 2019
